← Back to Search

Behavioral Intervention

Weight Loss Program for Obesity

N/A

Recruiting

Led By Evan Sisson

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Children

Timeline

Screening 3 weeks

Treatment Varies

Follow Up weekly for weeks 1-12, then monthly on weeks 16, 24, 28, 32 and 36

Awards & highlights

No Placebo-Only Group

Summary

This trial will test a program that includes patient education on weight loss and technology tools to help make healthy lifestyle choices.

Who is the study for?

This trial is for individuals with obesity who are preparing for a kidney transplant. Participants should be interested in weight loss and willing to use educational materials and technology tools designed to help them make healthier lifestyle choices.

What is being tested?

The study tests a program that combines patient education on weight loss with the use of tech tools to support healthy living. It's a single-arm feasibility study, meaning all participants receive the same intervention without comparison groups.

What are the potential side effects?

Since this trial focuses on education and lifestyle changes rather than medication, side effects may include typical challenges associated with weight loss such as hunger or fatigue but no medical side effects from drugs.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am under 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ weekly for weeks 1-12, then monthly on weeks 16, 24, 28, 32 and 36

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~weekly for weeks 1-12, then monthly on weeks 16, 24, 28, 32 and 36

This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly for weeks 1-12, then monthly on weeks 16, 24, 28, 32 and 36 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Meal recall survey

PrevenT2 education T

Quality of Life-Lite survey

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Subjects on the waiting list for kidney transplant at VCUHS with BMI greater than 35 kg/m2.Experimental Treatment3 Interventions

This project will be a single-arm feasibility study, with a treatment intervention that includes three interrelated components: (1) the use of medications for weight loss, (2) patient education using a proven weight loss curriculum, and (3) technology tools for making healthy lifestyle choices.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Blood draw

2021

Completed Phase 4

~7380

0 / 1Eligibility criteria met